[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-108-1-medical-surgical-080":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":22},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":10},"nurse-108-1-內外科護理學-080","nurse-108-1-medical-surgical-080",108,1,80,"有關 GFR 為 15 mL\u002Fmin\u002F1.73 m 2 之慢性腎臟病病人之護理指導，下列何者最適當？",{"A":14,"B":15,"C":16,"D":17},"介紹阻緩腎功能惡化的措施","介紹腎臟疾病相關知識","介紹透析治療通路","介紹透析治療合併症","C",null,[],"本題考點為慢性腎臟病分期與衛教重點的對應。GFR 15 mL\u002Fmin\u002F1.73m² 屬第五期（末期腎病，GFR＜15 為終末），已逼近需要腎臟替代治療的階段，此時衛教應聚焦於透析治療通路的預先建立（如動靜脈瘻管），以便及時開始透析，故選 C 最適當。選項 A 介紹延緩惡化措施較適用於早中期（第一至三期）尚有保留空間時。選項 B 介紹疾病基礎知識屬初診斷或早期的衛教重點。選項 D 介紹透析併發症通常是開始透析後或即將透析時的深化衛教，順位在建立通路之後。整體而言，末期首要是備妥通路以銜接透析。",[23,27,31,35,39,43],{"webId":24,"stem":25,"number":10,"year":26,"session":10},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":28,"stem":29,"number":30,"year":26,"session":10},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",2,{"webId":32,"stem":33,"number":34,"year":26,"session":10},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":26,"session":10},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":26,"session":10},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":26,"session":10},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840745035]